Apoptosis-modulating proteins
AssigneeTanox, Inc.
InventorsMichael C. Kiefer, Philip J. Barr
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel peptides and compositions capable of modulating apoptosis in cells, and to methods of modulating apoptosis employing the novel peptides and compositions of the invention. In one aspect, the invention is directed to novel homologs of bcl-2 designated CDN-1, CDN-2, and CDN-3, and fragments, variants, homologs and derivatives thereof, which are capable of modulating apoptosis.
Claims6
A substantially purified CDN protein comprising the amino acid sequence depicted in SEQ ID NO:7, or a fragment thereof lacking the first 59 or first 70 amino acid residues thereof or truncated after amino acid 1 12 thereof, where the fragment has apoptosis-modulating activity.
A substantially purified CDN protein comprising the amino acid sequence depicted in SEQ ID NO:9.
Dependencies are inferred from the claim text.